Regenicin Inc logo

Regenicin Inc

RGIN · OTC · Health Technology, Medical Specialties · Founded 2007

Regenicin, Inc. is a biotechnology company, which specializes in the development of regenerative cell therapies to restore the health of damaged tissues and organs.

Current Price
$0.00
Market Cap
$0K
Return Since Last Split
-100%
Last Split
Aug 2, 2010
Total Splits
1
Cumulative Multiple
34×

What If You Bought RGIN Earlier?

Investment
Purchase Date (Before Split)
Worth Today
$0
3,400 shares · 34×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
Aug 2, 2010$2.2034-for-134×34×

Regenicin Inc Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

Regenicin Inc's latest record in the split calendar is a 34-for-1 forward split effective 2010-08-02.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.